Will sequestration bite US FDA user fees?
This article was originally published in Clinica
Executive Summary
A US non-profit organisation has raised concerns that across-the-board federal spending cuts being introduced in January may not only take $200 million from the Food and Drug Administration's $2.5 billion appropriated funds, or about 8%, but that the user fees paid by industry could also get caught in that snare.